Table 2. Demographics of treated patients.
| Demographic | |
| Sex, n (%) | |
| Men | 23 (48) |
| Women | 25 (52) |
| Age, years | |
| Median (range) | 60 (21-83) |
| Race/Ethnicity, n (%) | |
| White | 38 (80) |
| Black | 5 (10) |
| Hispanic | 3 (6) |
| Native American | 2 (4) |
| Disease type, n (%) | |
| Sarcoma | 11 (23) |
| NSCLC | 10 (21) |
| Colorectal | 8 (17) |
| Melanoma | 5 (11) |
| Breast | 2 (4) |
| Ovarian | 2 (4) |
| Pancreatic | 2 (4) |
| Unknown primary | 2 (4) |
| Esophageal | 1 (2) |
| Cervical | 1 (2) |
| Liver | 1 (2) |
| Osteosarcoma | 1 (2) |
| Prostate | 1 (2) |
| Uterine | 1 (2) |
| ECOG performance status, n (%) | |
| 0 | 0 (0) |
| 1 | 34 (70) |
| 2 | 14 (30) |
| Median prior lines of chemotherapy (range) | |
| Chemotherapy | 3 (1-8) |
| Previous therapy, n (%) | |
| Chemotherapy | 47 (98) |
| Radiation | 19 (39) |
| Hormonal/endocrine | 3 (6) |
| Biologics/vaccines | 21 (43) |